| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1123931655 |
| P356 | DOI | 10.1016/J.VIROL.2020.01.004 |
| P932 | PMC publication ID | 7112099 |
| P698 | PubMed publication ID | 32056846 |
| P50 | author | Rebecca Ellis Dutch | Q89312730 |
| P2093 | author name string | Gary R Whittaker | |
| Jonathan T Kinder | |||
| Marco R Straus | |||
| Michal Segall | |||
| P2860 | cites work | Influenza pandemics of the 20th century | Q22305643 |
| Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice | Q24313255 | ||
| Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter | Q24634155 | ||
| Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma | Q28236057 | ||
| Avian influenza A (H5N1) infection in humans | Q28274603 | ||
| Drug resistance in influenza A virus: the epidemiology and management | Q30234600 | ||
| Role of hemagglutinin cleavage for the pathogenicity of influenza virus. | Q30322358 | ||
| Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. | Q30356975 | ||
| Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2. | Q30364158 | ||
| Pandemic influenza as a current threat. | Q30380878 | ||
| A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site | Q30400507 | ||
| Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus | Q30403023 | ||
| Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses | Q30424187 | ||
| Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase. | Q30427707 | ||
| Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation | Q30427818 | ||
| Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. | Q30432156 | ||
| The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses | Q33602849 | ||
| Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus | Q33752841 | ||
| A newly discovered human pneumovirus isolated from young children with respiratory tract disease | Q33845279 | ||
| Protease inhibitors targeting coronavirus and filovirus entry | Q34461982 | ||
| Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates | Q34651319 | ||
| HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. | Q35041020 | ||
| Influenza vaccines: challenges and solutions | Q35184572 | ||
| Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis | Q35735214 | ||
| Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma | Q35956303 | ||
| Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities | Q36276614 | ||
| Epidemiology of human metapneumovirus | Q36538868 | ||
| The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases. | Q36811980 | ||
| The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies | Q36827306 | ||
| Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12 | Q36929003 | ||
| Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity | Q36944800 | ||
| Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis | Q37610695 | ||
| TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice | Q37713993 | ||
| Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium | Q38118946 | ||
| Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation | Q39175999 | ||
| Airway proteases: an emerging drug target for influenza and other respiratory virus infections. | Q39246178 | ||
| Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. | Q39304996 | ||
| Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample | Q39352336 | ||
| Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer | Q39753803 | ||
| Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. | Q40041650 | ||
| Characterization of placental bikunin, a novel human serine protease inhibitor | Q41110972 | ||
| The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. | Q41112381 | ||
| A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice | Q41676300 | ||
| Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. | Q42259941 | ||
| Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT. | Q42730825 | ||
| Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease | Q43252092 | ||
| The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells | Q47171613 | ||
| Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression. | Q52676902 | ||
| Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. | Q55426854 | ||
| Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents | Q59353237 | ||
| Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil | Q60046097 | ||
| A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation | Q84316040 | ||
| HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis | Q91597625 | ||
| Human matriptase/ST 14 proteolytically cleaves H7N9 hemagglutinin and facilitates the activation of influenza A/Shanghai/2/2013 virus in cell culture | Q91837774 | ||
| Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis | Q91861500 | ||
| TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes | Q92482104 | ||
| Human metapneumovirus fusion protein triggering: Increasing complexities by analysis of new HMPV fusion proteins | Q92850658 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| ImageQuant | Q112270642 | ||
| P304 | page(s) | 43-53 | |
| P577 | publication date | 2020-01-07 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses | |
| P478 | volume | 543 |
| Q110245709 | Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry |
| Q107377038 | The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity |
Search more.